(Q34312617)

1 August 2017

title

Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia (English)

1 reference

1 August 2017

0 references

G M. Pasinetti

1

1 reference

1 August 2017

publication date

1 August 2001

1 reference

Archives of Gerontology and Geriatrics

1 August 2017

published in

1 reference

1 August 2017

volume

33

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

13-28

1 reference

Localization and cell association of C1q in Alzheimer's disease brain

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Expression and regulation of cyclooxygenase-2 in rat microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Cytokine actions in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Cyclo-oxygenase-2 messenger RNA induction in focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Safety profile of over-the-counter naproxen sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Estimation of the in vivo effect of cyclooxygenase inhibitors on prostaglandin E2 levels in mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

TGF-beta 1 is an organizer of responses to neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Inflammatory mechanisms in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Interferon-gamma and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

The Clinical Dementia Rating (CDR): current version and scoring rules

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Cyclooxygenase-2 is induced globally in infarcted human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Immunofluorescent localization of constitutive and inducible prostaglandin H synthase in ovine astroglia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

New insights into the mode of action of anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

Ibuprofen protects low density lipoproteins against oxidative modification

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900091-7

7 January 2021

10.1016/S0167-4943(01)00091-7

Identifiers

DOI

1 reference

1 August 2017

1 reference